Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin

<p>Abstract</p> <p>Background</p> <p>The genus <it>Nairovirus </it>in the family <it>Bunyaviridae </it>contains 34 tick-borne viruses classified into seven serogroups. Hazara virus (HAZV) belongs to the Crimean-Congo hemorrhagic fever (CCHF) sero...

Full description

Bibliographic Details
Main Authors: Crance Jean-Marc, Bouloy Michèle, Peyrefitte Christophe N, Vigne Solenne, Flusin Olivier, Iseni Frédéric
Format: Article
Language:English
Published: BMC 2011-05-01
Series:Virology Journal
Online Access:http://www.virologyj.com/content/8/1/249
_version_ 1818915526302236672
author Crance Jean-Marc
Bouloy Michèle
Peyrefitte Christophe N
Vigne Solenne
Flusin Olivier
Iseni Frédéric
author_facet Crance Jean-Marc
Bouloy Michèle
Peyrefitte Christophe N
Vigne Solenne
Flusin Olivier
Iseni Frédéric
author_sort Crance Jean-Marc
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>The genus <it>Nairovirus </it>in the family <it>Bunyaviridae </it>contains 34 tick-borne viruses classified into seven serogroups. Hazara virus (HAZV) belongs to the Crimean-Congo hemorrhagic fever (CCHF) serogroup that also includes CCHF virus (CCHFV) a major pathogen for humans. HAZV is an interesting model to study CCHFV due to a close serological and phylogenetical relationship and a classification which allows handling in a BSL2 laboratory. Nairoviruses are characterized by a tripartite negative-sense single stranded RNA genome (named L, M and S segments) that encode the RNA polymerase, the Gn-Gc glycoproteins and the nucleoprotein (NP), respectively. Currently, there are neither vaccines nor effective therapies for the treatment of any bunyavirus infection in humans. In this study we report, for the first time, the use of RNA interference (RNAi) as an approach to inhibit nairovirus replication.</p> <p>Results</p> <p>Chemically synthesized siRNAs were designed to target the mRNA produced by the three genomic segments. We first demonstrated that the siRNAs targeting the NP mRNA displayed a stronger antiviral effect than those complementary to the L and M transcripts in A549 cells. We further characterized the two most efficient siRNAs showing, that the induced inhibition is specific and associated with a decrease in NP synthesis during HAZV infection. Furthermore, both siRNAs depicted an antiviral activity when used before and after HAZV infection. We next showed that HAZV was sensitive to ribavirin which is also known to inhibit CCHFV. Finally, we demonstrated the additive or synergistic antiviral effect of siRNAs used in combination with ribavirin.</p> <p>Conclusions</p> <p>Our study highlights the interest of using RNAi (alone or in combination with ribavirin) to treat nairovirus infection. This approach has to be considered for the development of future antiviral compounds targeting CCHFV, the most pathogenic nairovirus.</p>
first_indexed 2024-12-20T00:03:41Z
format Article
id doaj.art-4efe8052154148f1b6006394f38a8a43
institution Directory Open Access Journal
issn 1743-422X
language English
last_indexed 2024-12-20T00:03:41Z
publishDate 2011-05-01
publisher BMC
record_format Article
series Virology Journal
spelling doaj.art-4efe8052154148f1b6006394f38a8a432022-12-21T20:00:44ZengBMCVirology Journal1743-422X2011-05-018124910.1186/1743-422X-8-249Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirinCrance Jean-MarcBouloy MichèlePeyrefitte Christophe NVigne SolenneFlusin OlivierIseni Frédéric<p>Abstract</p> <p>Background</p> <p>The genus <it>Nairovirus </it>in the family <it>Bunyaviridae </it>contains 34 tick-borne viruses classified into seven serogroups. Hazara virus (HAZV) belongs to the Crimean-Congo hemorrhagic fever (CCHF) serogroup that also includes CCHF virus (CCHFV) a major pathogen for humans. HAZV is an interesting model to study CCHFV due to a close serological and phylogenetical relationship and a classification which allows handling in a BSL2 laboratory. Nairoviruses are characterized by a tripartite negative-sense single stranded RNA genome (named L, M and S segments) that encode the RNA polymerase, the Gn-Gc glycoproteins and the nucleoprotein (NP), respectively. Currently, there are neither vaccines nor effective therapies for the treatment of any bunyavirus infection in humans. In this study we report, for the first time, the use of RNA interference (RNAi) as an approach to inhibit nairovirus replication.</p> <p>Results</p> <p>Chemically synthesized siRNAs were designed to target the mRNA produced by the three genomic segments. We first demonstrated that the siRNAs targeting the NP mRNA displayed a stronger antiviral effect than those complementary to the L and M transcripts in A549 cells. We further characterized the two most efficient siRNAs showing, that the induced inhibition is specific and associated with a decrease in NP synthesis during HAZV infection. Furthermore, both siRNAs depicted an antiviral activity when used before and after HAZV infection. We next showed that HAZV was sensitive to ribavirin which is also known to inhibit CCHFV. Finally, we demonstrated the additive or synergistic antiviral effect of siRNAs used in combination with ribavirin.</p> <p>Conclusions</p> <p>Our study highlights the interest of using RNAi (alone or in combination with ribavirin) to treat nairovirus infection. This approach has to be considered for the development of future antiviral compounds targeting CCHFV, the most pathogenic nairovirus.</p>http://www.virologyj.com/content/8/1/249
spellingShingle Crance Jean-Marc
Bouloy Michèle
Peyrefitte Christophe N
Vigne Solenne
Flusin Olivier
Iseni Frédéric
Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin
Virology Journal
title Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin
title_full Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin
title_fullStr Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin
title_full_unstemmed Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin
title_short Inhibition of Hazara nairovirus replication by small interfering RNAs and their combination with ribavirin
title_sort inhibition of hazara nairovirus replication by small interfering rnas and their combination with ribavirin
url http://www.virologyj.com/content/8/1/249
work_keys_str_mv AT crancejeanmarc inhibitionofhazaranairovirusreplicationbysmallinterferingrnasandtheircombinationwithribavirin
AT bouloymichele inhibitionofhazaranairovirusreplicationbysmallinterferingrnasandtheircombinationwithribavirin
AT peyrefittechristophen inhibitionofhazaranairovirusreplicationbysmallinterferingrnasandtheircombinationwithribavirin
AT vignesolenne inhibitionofhazaranairovirusreplicationbysmallinterferingrnasandtheircombinationwithribavirin
AT flusinolivier inhibitionofhazaranairovirusreplicationbysmallinterferingrnasandtheircombinationwithribavirin
AT isenifrederic inhibitionofhazaranairovirusreplicationbysmallinterferingrnasandtheircombinationwithribavirin